Cinctive Capital Management LP Invests $5.75 Million in Waters Corporation $WAT

Key Points

• Cinctive Capital Management LP has acquired 15,592 shares of Waters Corporation, valued at approximately $5.7 million, indicating a significant institutional investment in the company during Q1.
• Waters Corporation reported earnings of $2.95 per share for the most recent quarter, exceeding analysts' expectations and demonstrating a revenue growth of 8.8% year-over-year.
• Shares of Waters have a wide trading range, opening at $289.79, with a 1-year low of $275.05 and high of $423.56, alongside a market cap of $17.25 billion.

Cinctive Capital Management LP purchased a new position in Waters Corporation (NYSE:WAT - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 15,592 shares of the medical instruments supplier's stock, valued at approximately $5,747,000.

Several other large investors have also recently added to or reduced their stakes in the stock. Olde Wealth Management LLC acquired a new position in shares of Waters in the first quarter worth $25,000. Zions Bancorporation National Association UT acquired a new position in Waters in the 1st quarter worth about $28,000. IFP Advisors Inc raised its stake in shares of Waters by 118.9% during the 1st quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier's stock worth $30,000 after purchasing an additional 44 shares in the last quarter. Whipplewood Advisors LLC grew its stake in shares of Waters by 5,200.0% in the 1st quarter. Whipplewood Advisors LLC now owns 106 shares of the medical instruments supplier's stock valued at $39,000 after buying an additional 104 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd acquired a new position in Waters in the first quarter worth approximately $41,000. Institutional investors and hedge funds own 94.01% of the company's stock.

Waters Stock Performance

WAT traded down $9.65 during midday trading on Tuesday, reaching $299.72. The company's stock had a trading volume of 576,921 shares, compared to its average volume of 612,311. The company has a current ratio of 1.75, a quick ratio of 1.22 and a debt-to-equity ratio of 0.55. The company has a fifty day simple moving average of $303.98 and a 200 day simple moving average of $335.03. The stock has a market cap of $17.84 billion, a P/E ratio of 27.04, a PEG ratio of 2.86 and a beta of 1.07. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $423.56.

Waters (NYSE:WAT - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.93 by $0.02. The business had revenue of $771.33 million for the quarter, compared to analyst estimates of $745.96 million. Waters had a return on equity of 38.60% and a net margin of 21.71%.The firm's revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.63 earnings per share. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. Research analysts expect that Waters Corporation will post 12.86 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts have issued reports on WAT shares. Robert W. Baird reduced their target price on shares of Waters from $374.00 to $352.00 and set an "outperform" rating for the company in a research note on Wednesday, July 16th. Wall Street Zen cut shares of Waters from a "buy" rating to a "hold" rating in a report on Saturday, July 26th. Bank of America increased their target price on shares of Waters from $370.00 to $375.00 and gave the stock a "neutral" rating in a research report on Thursday, June 26th. Scotiabank reiterated a "sector outperform" rating and set a $465.00 price target on shares of Waters in a research note on Friday, July 11th. Finally, UBS Group reissued a "neutral" rating on shares of Waters in a research note on Tuesday, July 15th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and nine have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $378.73.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.